Although we did not observe abundant expression of IL6 by cancer cells in our model, the level of IL6 in the blood of advanced PDAC patients is high51, which suggests that circulating IL6 could also contribute to the expression of Osteopontin (Spp1) and, accordingly, the pro-metastatic functions of myMAFs. The gene discussed is IL6; the disease is cancer.